Company Information
- Type:
- Company
- Country:
- Singapore
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 30 October 2019 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 26-Jul-2024 | 2024 Communication on Progress | Submitted |
| 28-Dec-2023 | 2023 Communication on Progress | Submitted |
| 12-Apr-2022 | 2021 GRI Sustainability Report | Active |
| 22-Feb-2022 | Grace Letter | Not applicable |
| 28-Jan-2021 | Zuellig Pharma Communication on Progress 2020 | Active |
| 03-Dec-2020 | Reporting Cycle Adjustment | Not applicable |
| 11-Dec-2019 | Zuellig Pharma Communication on Progress | Active |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.